| Primary |
| Breast Cancer |
43.1% |
| Hodgkin's Disease |
10.6% |
| Non-hodgkin's Lymphoma |
10.4% |
| Multiple Myeloma |
4.8% |
| Lymphoma |
4.4% |
| Burkitt's Lymphoma |
3.9% |
| Adult T-cell Lymphoma/leukaemia |
2.8% |
| Diffuse Large B-cell Lymphoma |
2.8% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
2.5% |
| Acute Lymphocytic Leukaemia |
2.2% |
| Primary Effusion Lymphoma |
2.1% |
| Prostate Cancer |
1.7% |
| Chronic Myeloid Leukaemia |
1.5% |
| Leukaemia Plasmacytic |
1.2% |
| Bone Sarcoma |
1.1% |
| Endometrial Cancer |
1.1% |
| Ill-defined Disorder |
1.1% |
| Hodgkin's Disease Stage Iv |
1.0% |
| Neuroblastoma |
1.0% |
| Breast Cancer Metastatic |
0.8% |
|
| Febrile Neutropenia |
12.5% |
| Vomiting |
8.3% |
| Sepsis |
7.6% |
| Pneumonia |
6.9% |
| Neutropenia |
5.6% |
| Nausea |
4.9% |
| Pulmonary Toxicity |
4.9% |
| Pyrexia |
4.9% |
| Cardiac Failure Congestive |
4.2% |
| Cardiomyopathy |
4.2% |
| Cellulitis |
4.2% |
| Osteonecrosis |
4.2% |
| Renal Failure Acute |
4.2% |
| Thrombocytopenia |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Pancytopenia |
3.5% |
| Pneumonitis |
3.5% |
| Cardiac Failure |
2.8% |
| Colitis |
2.8% |
| Death |
2.8% |
|
| Secondary |
| Multiple Myeloma |
21.9% |
| Breast Cancer |
16.6% |
| Hodgkin's Disease |
14.7% |
| Non-hodgkin's Lymphoma |
7.0% |
| Drug Use For Unknown Indication |
6.9% |
| Acute Lymphocytic Leukaemia |
4.3% |
| Diffuse Large B-cell Lymphoma |
4.2% |
| Lymphoma |
3.0% |
| B-cell Lymphoma |
2.9% |
| Product Used For Unknown Indication |
2.6% |
| Chemotherapy |
2.5% |
| Prophylaxis |
2.3% |
| Burkitt's Lymphoma |
1.8% |
| Mantle Cell Lymphoma |
1.7% |
| Breast Cancer Metastatic |
1.5% |
| Bone Sarcoma |
1.4% |
| Adult T-cell Lymphoma/leukaemia |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Hypertension |
1.1% |
| Pain |
1.1% |
|
| Febrile Neutropenia |
10.2% |
| Pyrexia |
8.8% |
| Vomiting |
8.8% |
| Sepsis |
7.5% |
| Thrombocytopenia |
7.1% |
| Myocarditis |
5.2% |
| Pneumonia |
5.2% |
| Acute Myeloid Leukaemia |
4.8% |
| White Blood Cell Count Decreased |
4.6% |
| Death |
4.4% |
| Neutropenia |
4.0% |
| Hypothyroidism |
3.8% |
| Maternal Exposure During Pregnancy |
3.5% |
| Stomatitis |
3.5% |
| Treatment Related Secondary Malignancy |
3.5% |
| Pancytopenia |
3.3% |
| Hepatitis B |
3.1% |
| Myelodysplastic Syndrome |
2.9% |
| Osteonecrosis |
2.9% |
| Pneumonitis |
2.9% |
|
| Concomitant |
| Breast Cancer |
18.5% |
| Multiple Myeloma |
16.5% |
| Chemotherapy |
9.6% |
| Breast Cancer Metastatic |
6.8% |
| Metastases To Bone |
6.7% |
| Pain |
5.1% |
| Prophylaxis |
5.0% |
| Drug Use For Unknown Indication |
3.4% |
| Non-hodgkin's Lymphoma |
3.2% |
| Product Used For Unknown Indication |
3.1% |
| B-cell Lymphoma |
3.1% |
| Hypertension |
2.8% |
| Hodgkin's Disease |
2.7% |
| Depression |
2.3% |
| Diffuse Large B-cell Lymphoma |
2.2% |
| Nuclear Magnetic Resonance Imaging |
2.1% |
| Neoplasm Malignant |
2.0% |
| Lymphoma |
1.8% |
| Eczema |
1.5% |
| Acute Lymphocytic Leukaemia |
1.4% |
|
| Weight Decreased |
12.8% |
| Vomiting |
9.3% |
| Tooth Extraction |
7.9% |
| Weight Increased |
6.5% |
| Febrile Neutropenia |
6.3% |
| White Blood Cell Count Increased |
5.6% |
| White Blood Cell Count Decreased |
4.6% |
| Wound Drainage |
4.6% |
| Pyrexia |
4.4% |
| Thrombocytopenia |
4.0% |
| Wheelchair User |
3.9% |
| Wound Dehiscence |
3.9% |
| Dyspnoea |
3.7% |
| Wound Treatment |
3.7% |
| Neutropenia |
3.5% |
| Wheezing |
3.5% |
| Wound Secretion |
3.3% |
| Wound Debridement |
3.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.8% |
| X-ray Abnormal |
2.8% |
|
| Interacting |
| Hodgkin's Disease |
40.0% |
| Prophylaxis Of Nausea And Vomiting |
20.0% |
| Anxiety |
10.0% |
| Breast Cancer |
10.0% |
| Bronchopulmonary Aspergillosis |
10.0% |
| Supraventricular Tachycardia |
10.0% |
|
| Drug Interaction |
25.0% |
| Infusion Site Phlebitis |
25.0% |
| Middle Insomnia |
25.0% |
| Palpitations |
25.0% |
|
